<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HF9002844E88A43C3990F3BBDD06DEE67" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 976 IH: Ensuring Transparent Honest Information on COVID–19 Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2021-02-11</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 976</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20210211">February 11, 2021</action-date><action-desc><sponsor name-id="C001066">Ms. Castor of Florida</sponsor> (for herself and <cosponsor name-id="U000040">Ms. Underwood</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HGO00">Committee on Oversight and Reform</committee-name>, and in addition to the Committee on <committee-name committee-id="HIF00">Energy and Commerce</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Public Health Service Act to expand, enhance, and improve applicable public health data systems used by the Centers for Disease Control and Prevention, and for other purposes.</official-title></form><legis-body id="H7F06BAF41B8548278341DF283ED60DEF" style="OLC"><section id="H1C785C4C37044929A148BFA7F1A7E646" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Ensuring Transparent Honest Information on COVID–19 Act</short-title></quote> or the <quote><short-title>ETHIC Act</short-title></quote>.</text></section><section id="H821071FD36B74956A0B11977AB04E3CE"><enum>2.</enum><header>Required reporting by State, local, Tribal, or Territorial governments regarding COVID–19</header><subsection id="HCD18EF6A1CE846B9B7EB570069E181CB"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">As a condition on receipt of funds through a covered grant or cooperative agreement, a State, local, Tribal, or Territorial government shall agree to direct the appropriate State, local, Tribal, or Territorial governmental entity (including any public health department thereof) to report to the Centers for Disease Control and Prevention, with respect to the jurisdiction involved and COVID–19—</text><paragraph id="H9CEB713FB9004870AAA8DD8F0117CB50"><enum>(1)</enum><text>on a daily basis, the information listed in subsection (d); and</text></paragraph><paragraph id="H7B342EB1B47A4247B8693487B5BA6A4A"><enum>(2)</enum><text>on a weekly basis, the information listed in subsection (e).</text></paragraph></subsection><subsection id="HE8936579B5344CFAAC758CC26B5EDF86"><enum>(b)</enum><header>Tribal waiver</header><paragraph id="H1DFCD21682B043BAA90E291068C4F142"><enum>(1)</enum><header>Review and disposition</header><text>Upon the receipt of a written request from a Tribal government, or consortia thereof, for a waiver of the conditions specified in paragraphs (1) and (2) of subsection (a), the Director of the Centers for Disease Control and Prevention shall, not later than 30 days after receipt of such request, approve or deny it.</text></paragraph><paragraph id="H485A035BFCD84388BBD5812230A24886"><enum>(2)</enum><header>Denials</header><text display-inline="yes-display-inline">In the case of a denial of a request under paragraph (1), the Director of the Centers for Disease Control and Prevention shall—</text><subparagraph id="H392288905D1D49D1AE272286B8872FCA"><enum>(A)</enum><text>provide to the requestor a written explanation of the reasons for the denial; and</text></subparagraph><subparagraph id="H9738BB6B138B4F488FE297838984666B"><enum>(B)</enum><text>provide the requestor with an opportunity to correct any deficiencies in the request.<italic></italic></text></subparagraph></paragraph></subsection><subsection id="H8B854EA61656448099017A3047C11614"><enum>(c)</enum><header>Covered grant or cooperative agreement</header><text display-inline="yes-display-inline">For purposes of this section, a covered grant or cooperative agreement is any grant or cooperative agreement awarded under any of the following laws (including any amendment made thereby):</text><paragraph id="H767DD3BFAE2C458CB5EDF3EEE9542C01"><enum>(1)</enum><text display-inline="yes-display-inline">The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (<external-xref legal-doc="public-law" parsable-cite="pl/116/123">Public Law 116–123</external-xref>).</text></paragraph><paragraph id="HDBCC3DD7ABEF4CA4875DC007D46EC8AE"><enum>(2)</enum><text>The Families First Coronavirus Response Act (<external-xref legal-doc="public-law" parsable-cite="pl/116/127">Public Law 116–127</external-xref>).</text></paragraph><paragraph id="H309F05B23FCB41ABAA97098DD1DF1BE3"><enum>(3)</enum><text display-inline="yes-display-inline"> The CARES Act (<external-xref legal-doc="public-law" parsable-cite="pl/116/136">Public Law 116–136</external-xref>).</text></paragraph><paragraph id="H95478FF0104A4C98A5A65982E5DABFB0"><enum>(4)</enum><text>The Paycheck Protection Program and Health Care Enhancement Act (<external-xref legal-doc="public-law" parsable-cite="pl/116/139">Public Law 116–139</external-xref>).</text></paragraph><paragraph id="H99569C467B3E46069FBF9C373A04CE3D"><enum>(5)</enum><text display-inline="yes-display-inline">The Consolidated Appropriations Act, 2021 (<external-xref legal-doc="public-law" parsable-cite="pl/116/260">Public Law 116–260</external-xref>).</text></paragraph></subsection><subsection id="H2AA3F69F4B7144F6BABD86DD4FF06540"><enum>(d)</enum><header>Daily reporting</header><text>The information to be reported daily pursuant to subsection (a)(1) consists of the following, disaggregated to the county level if applicable:</text><paragraph id="HEEC0D106EB2D4075BD32DFE0F8C9EAD7"><enum>(1)</enum><text>Demographic characteristics, including, in a de-identified, disaggregated, and stratified manner, race, ethnicity, age, sex, geographic region, and other relevant factors of individuals tested for or diagnosed with COVID–19, to the extent such information is available.</text></paragraph><paragraph id="H08873F0DCDC64F2D8BFE0BEAE57FE2A9"><enum>(2)</enum><text display-inline="yes-display-inline">The number of adults with a confirmed case of COVID–19 who are hospitalized in an intensive care bed.</text></paragraph><paragraph id="H3040BDECFD5E42E8BAC9D03FC6B56008"><enum>(3)</enum><text display-inline="yes-display-inline">The number of adults with a suspected case of COVID–19 who are hospitalized in an intensive care bed.</text></paragraph><paragraph id="H3AE642BA6CAD4C578D5F7F6F2EDAF782"><enum>(4)</enum><text>The number of adults with a confirmed case of COVID–19 who are hospitalized in an inpatient care bed.</text></paragraph><paragraph id="HC084723DEE7E46208BC3DEA00420271D"><enum>(5)</enum><text>The number of adults with a suspected case of COVID–19 who are hospitalized in an inpatient care bed.</text></paragraph><paragraph id="HAF39A93A4FE84DC3B84AA96C869C4A76"><enum>(6)</enum><text>The number of children with a confirmed case of COVID–19 who are hospitalized in an intensive care bed.</text></paragraph><paragraph id="H9C57325A5E924713BC3D545BAE05443B"><enum>(7)</enum><text>The number of children with a suspected case of COVID–19 who are hospitalized in an intensive care bed.</text></paragraph><paragraph id="H5BF559451A194B44999BA2413E1B28CA"><enum>(8)</enum><text>The number of children with a confirmed case of COVID–19 who are hospitalized in an inpatient care bed.</text></paragraph><paragraph id="H372DF4BFFEB64AD193F27D1EB53C882E"><enum>(9)</enum><text>The number of children with a suspected case of COVID–19 who are hospitalized in an inpatient care bed.</text></paragraph><paragraph id="H8885FE086A0D47C6BE5B46288908F1BA"><enum>(10)</enum><text>Out of the maximum number of beds for which hospitals are licensed to operate, the percentage occupied by confirmed or suspected COVID–19 patients.</text></paragraph><paragraph id="H3545097D12AF437CA8A64614C71D05B7"><enum>(11)</enum><text>Total staffed hospital beds.</text></paragraph><paragraph id="HBA390865F9AB4214AD185D6B2AD83823"><enum>(12)</enum><text>The numbers of diagnostic and serological tests administered for COVID–19, disaggregated and stratified by—</text><subparagraph id="HE77648D47178462B96F4D0B7299976CF"><enum>(A)</enum><text display-inline="yes-display-inline">the type of test (molecular and antigen); and</text></subparagraph><subparagraph id="HEEFDA8F341B44183A5C127200014099C"><enum>(B)</enum><text>the testing positivity rate of each type of test.</text></subparagraph></paragraph><paragraph id="H4AC776957D9244769E45933BE15ABF14"><enum>(13)</enum><text display-inline="yes-display-inline">The median turnaround time for diagnostic tests stratified by molecular and antigen tests.</text></paragraph><paragraph id="HF383EE43133C485EAB1D08086BFBCEF6"><enum>(14)</enum><text>The percentage of new cases of COVID–19 linked to at least one other case and, if such new cases are part of a known outbreak, identification of such outbreak.</text></paragraph><paragraph id="HB3D887573E03430DA14B25CF459E5B76"><enum>(15)</enum><text>The rate of transmission of COVID–19.</text></paragraph><paragraph id="H124588BE08954AFF87FC5F8DE3797CEC"><enum>(16)</enum><text display-inline="yes-display-inline">The number of confirmed and probable deaths as a result of COVID–19, de-identified and stratified by race, ethnicity, age, sex, geographic region, and other relevant factors.</text></paragraph><paragraph id="HFB30AAF5F52D46748FEB609A8B233686" commented="no"><enum>(17)</enum><text display-inline="yes-display-inline">The number of residents in nursing homes and assisted living facilities with a suspected or confirmed case of COVID–19.</text></paragraph><paragraph id="H6F0A24504932435CB77A901A64F7816E" commented="no"><enum>(18)</enum><text display-inline="yes-display-inline">The number of residents in nursing homes and assisted living facilities who have died from COVID–19.</text></paragraph><paragraph id="HC26CB29FEF49421ABDEF5F35BD0ED6D7" commented="no"><enum>(19)</enum><text display-inline="yes-display-inline">The number of staff in nursing homes and assisted living facilities with a suspected or confirmed case of COVID–19.</text></paragraph><paragraph id="H33007DC242924472BBBB61B99B7F93EB"><enum>(20)</enum><text>Such other information as the Director of the Centers for Disease Control and Prevention deems to be relevant.</text></paragraph></subsection><subsection id="HC478EDED1CC7439594E9F795C80D3BA3"><enum>(e)</enum><header>Weekly reporting</header><text display-inline="yes-display-inline">The information to be reported weekly pursuant to subsection (a)(2) consists of the following, disaggregated to the county level if applicable:</text><paragraph id="H7EAF768615D94DAF8C4B13D952808D44"><enum>(1)</enum><text>New infections of health care workers not confirmed to have contracted COVID–19 outside of the workplace.</text></paragraph><paragraph id="H5C875C4D3B5D41DF82D19FEB781ACB07"><enum>(2)</enum><text display-inline="yes-display-inline">The median time between collection of specimens for diagnostic tests for COVID–19 and isolation of cases.</text></paragraph><paragraph id="HF61ACFC891764409A752DD1511AE50A2"><enum>(3)</enum><text display-inline="yes-display-inline">The percentage of new cases of COVID–19 among quarantined contacts.</text></paragraph><paragraph id="H0BFF1E9BB56242BFB2E6B5E1E1B85FFB" commented="no"><enum>(4)</enum><text display-inline="yes-display-inline">The following information, in a manner that is de-identified, and is disaggregated and stratified by race, ethnicity, age, sex, geographic region, and other relevant factors, to the extent such information is available:</text><subparagraph id="H837B2366E07B4CD197E5811B71619D31" commented="no"><enum>(A)</enum><text display-inline="yes-display-inline">New suspected and confirmed cases of COVID–19 per 100,000 individuals.</text></subparagraph><subparagraph id="HB8AB80DAB1FD470FBF3762A25131E2F7" commented="no"><enum>(B)</enum><text display-inline="yes-display-inline">The percent change in new suspected and confirmed cases of COVID–19 per 100,000 individuals.</text></subparagraph><subparagraph id="HE734BFD6B1AB4D65BFE945FB140D4D43" commented="no"><enum>(C)</enum><text display-inline="yes-display-inline">The number of COVID–19 vaccine doses administered.</text></subparagraph><subparagraph id="H1373C43408FF4C10AF5D6052E2EC27CB" commented="no"><enum>(D)</enum><text display-inline="yes-display-inline">The number of individuals receiving a first dose of COVID–19 vaccine.</text></subparagraph><subparagraph id="H519D95F7A4FA44BF82D32B4A5419E938" commented="no"><enum>(E)</enum><text display-inline="yes-display-inline">The number of individuals completing a vaccination course for COVID–19.</text></subparagraph></paragraph><paragraph id="H0832E27B824E425B9E087E7BA0D513DB" commented="no"><enum>(5)</enum><text display-inline="yes-display-inline">The number of COVID–19 vaccine doses received by the reporting State, local, Tribal, or Territorial government, disaggregated by supplier.</text></paragraph><paragraph id="HF0E57488755B4382B03E9E8450F5B305" commented="no"><enum>(6)</enum><text display-inline="yes-display-inline">The number of nursing home and assisted living residents who have received a first dose of COVID–19 vaccine.</text></paragraph><paragraph id="H548472E1E8B943DAAC0F5AF8FD7269B5" commented="no"><enum>(7)</enum><text display-inline="yes-display-inline">The number of nursing home and assisted living residents who have completed a vaccination course for COVID–19.</text></paragraph><paragraph id="H533A82EEFB644CACAFBCC5B0DB598CFE"><enum>(8)</enum><text>Such other information as the Director of the Centers for Disease Control and Prevention deems to be relevant.</text></paragraph></subsection><subsection id="HC4A65F6703CF49049CBEBA324B0E02A6"><enum>(f)</enum><header>Public posting of reported data</header><text display-inline="yes-display-inline">On a daily basis, the Director of the Centers for Disease Control and Prevention shall make the information reported pursuant to this section, excluding personally identifiable information, publicly available on the website of the Centers for Disease Control and Prevention.</text></subsection><subsection id="H596113B41BA74C638F6B31890D29E5D8"><enum>(g)</enum><header>Applicability</header><text display-inline="yes-display-inline">The condition on funding in subsection (a) applies with respect to the obligation and expenditure by the Federal Government of funds through a covered grant or cooperative agreement on or after the date of enactment of this Act, including with respect to covered grants and cooperative agreements awarded before such date.</text></subsection></section><section id="HBB4C3BFB1D8A4E33A18C5BF48EF56E67"><enum>3.</enum><header>Study examining public health data and infrastructure necessary during and after the COVID–19 public health emergency</header><subsection id="HEFD7C840806F4F55A66DFC83B1E25DBB"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services (in this section referred to as the <quote>Secretary</quote>) shall seek to enter into a contract with the National Academies of Sciences, Engineering, and Medicine (referred to in this section as the <quote>National Academies</quote>) not later than 30 days after the date of enactment of this Act, under which the National Academies agree to conduct a study with stakeholders from Federal agencies, State, Tribal, Territorial, and local governments, research institutions, industry, and nonprofit organizations that would review the current system for public health data infrastructure and reporting and provide recommendations on needed data and system improvements for future pandemics and ongoing public health needs.</text></subsection><subsection id="H907666EBFC444EE8BF8F48D51EEF960D"><enum>(b)</enum><header>Submission of report</header><text>The contract under subsection (a) shall require that the study under such subsection be completed, and a report on the resulting recommendations be submitted to the Secretary, the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, not later than 12 months after the date the contract was executed.</text></subsection><subsection id="HA3BF2BFE2A224E5480E63001734070F6"><enum>(c)</enum><header>Study topics</header><text>The contract under subsection (a) shall require the study under such subsection to—</text><paragraph id="H27D1912BB6BD4C1CBCE42DDC63EB405E"><enum>(1)</enum><text>review the current public health data systems and the reporting structure for Federal, State, Tribal, Territorial, and local public health information, including vital records;</text></paragraph><paragraph id="H9CA7682CB53246A5A5CBB7598A77303F"><enum>(2)</enum><text>review current standards for reporting, quality controls, and transparency of the data;</text></paragraph><paragraph id="HE4AED52234784084AB000B4276039AEE"><enum>(3)</enum><text>examine data gaps and barriers to timely and accurate reporting and identify ways to fill those gaps;</text></paragraph><paragraph id="HFE425DE659B945F8AE1C2B30A7DDED3F"><enum>(4)</enum><text>examine how systems can be accessed and used by a wide range of users, including external researchers;</text></paragraph><paragraph id="H585CB70C2C61497B8DA47B7DC5743C1B"><enum>(5)</enum><text>examine how different data systems interact and how different data sources can be integrated;</text></paragraph><paragraph id="H673A6D4F36C340FE90313B7DD7A409AC"><enum>(6)</enum><text>examine nontraditional data sources or alternative data gathering methods that could be used to complement traditionally collected data;</text></paragraph><paragraph id="H3168C3A4B0FF49C69725577334686ABE"><enum>(7)</enum><text display-inline="yes-display-inline">identify needed improvements to the public health data systems and structure, especially with regard to the needs of Tribal systems;</text></paragraph><paragraph id="H47B0633DF38640DE8E22AF91B0EB687B"><enum>(8)</enum><text>identify core elements of a <quote>minimum data set</quote> that might be used for State population surveillance, including demographic components that are necessary to ensure health equity in public health decision making;</text></paragraph><paragraph id="H2BCF7588D1C2455099D0C8290E14762A"><enum>(9)</enum><text display-inline="yes-display-inline">examine how surveillance systems can be explicitly designed to ensure underserved populations (which may include racial and ethnic minorities, immigrants, individuals in nursing homes, other institutionalized populations, and individuals experiencing homelessness) are included in reporting;</text></paragraph><paragraph id="HA11A0E6DE50E47EFA9A11B782B4AD1C2"><enum>(10)</enum><text>consider how traditional and nontraditional data might be used to promote health equity across the United States and reduce racial, Tribal, and other demographic disparities;</text></paragraph><paragraph id="H576724B78C1F4F86A481BC88617EFE58"><enum>(11)</enum><text>examine data gaps and barriers to collecting, analyzing, and using demographic data to characterize the COVID–19 pandemic for public health action and research to improve public health actions and identify ways to fill those gaps; and</text></paragraph><paragraph id="H4B580B4E62274613A79DBFE082E2C080"><enum>(12)</enum><text>report on what is known based on existing data about how COVID–19 is impacting subgroups of the population with respect to access to testing, treatment, and vaccination (hospitalization and access to drugs and medical equipment), and health outcomes (morbidity and mortality). </text></paragraph></subsection><subsection id="H0A36886E7AF54C33B1F9683E66CC6A64"><enum>(d)</enum><header>Disaggregation of data</header><text display-inline="yes-display-inline">To the extent feasible, the contract under subsection (a) shall require data to be disaggregated by race, ethnicity, age, gender, disability, geography, language, socioeconomic status, and other factors.</text></subsection><subsection id="H9B9601C9766648EB942DF062FA45D059"><enum>(e)</enum><header>Authorization of appropriations</header><text>To carry out this section, there is authorized to be appropriated $1,000,000, to remain available until expended.</text></subsection></section></legis-body></bill> 

